Antiatherosclerotic Effects of ACE Inhibitors: Where Are We Now?

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.1, Iss.5, 2001-01, pp. : 315-320

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphodiesterase 4 Inhibitors and the Treatment of Asthma: Where Are We Now and Where Do We Go from Here?

By Giembycz M.A.

Drugs, Vol. 59, Iss. 2, 2000-02 ,pp. : 193-212

Adis International

Access to resources Recommend Favorite

Intermediate care – where are we now?

By Harari Danielle

Clinical Medicine, Vol. 2, Iss. 5, 2002-09 ,pp. : 477-479

Royal College Of Physicians

Access to resources Recommend Favorite

Discovery and ADMET: Where Are We Now

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 4, 2011-02 ,pp. : 467-481

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of ACE Inhibitors on Skeletal Muscle

Current Pharmaceutical Design, Vol. 12, Iss. 16, 2006-06 ,pp. : 2057-2064

Bentham Science Publishers

Access to resources Recommend Favorite

The Second Window of Preconditioning (SWOP) Where Are We Now?

By Hausenloy Derek Yellon Derek

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 3, 2010-06 ,pp. : 235-254

Springer Publishing Company

Access to resources Recommend Favorite